Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | KCNN4 | O15554 | 8/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1706265 | 1.00 | MAPT (0.65) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL1706268 | 1.00 | MAPT (0.65) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Hydrochloric Acid SCHEMBL16776633 | 0.98 | MAPT (0.63) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL29758021 | 0.88 | MAPT (0.57) | MAPTKMT2AKCNN4 | |
| SCHEMBL59841 | 0.84 | CYP1A2 (0.58) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL5181868 | 0.84 | MAPT (0.56) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL222049 | 0.84 | CYP1A2 (0.58) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL220775 | 0.84 | CYP1A2 (0.58) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Hydrochloric Acid SCHEMBL304449 | 0.82 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Hydrochloric Acid SCHEMBL1455022 | 0.82 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2CYP2D6KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3157919-A1 | BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS | Bayer Pharma Aktiengesellschaft (DE) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015193219-A1 | BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-12-23 | — | — | WO | disclosed |
| EP-2203562-B1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERICALLY AND/OR DIASTEREOMERICALLY ENRICHED ESTER, THIOESTER, ALCOHOL OR THIOL | DSM IP ASSETS BV (NL) | 2012-04-18 | — | — | EP | disclosed |
| US-20100304451-A1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERICALLY AND/OR DIASTEREOMERICALLY ENRICHED ESTER, THIOESTER, ALCOHOL OR THIOL | DSM IP ASSETS B.V. (NL) | 2010-12-02 | — | — | US | disclosed |
| EP-2203562-A1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERICALLY AND/OR DIASTEREOMERICALLY ENRICHED ESTER, THIOESTER, ALCOHOL OR THIOL | DSM IP Assets B.V. (NL) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009050216-A1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERICALLY AND/OR DIASTEREOMERICALLY ENRICHED ESTER, THIOESTER, ALCOHOL OR THIOL | DSM IP ASSETS BV (NL) | 2009-04-23 | — | — | WO | disclosed |
| US-20070196904-A1 | Method for the production of chiral secondary alcohols | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2007-08-23 | — | — | US | disclosed |
| EP-1725674-A1 | METHOD FOR THE PRODUCTION OF CHIRAL, SECONDARY ALCOHOLS | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005095629-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ESTERS AND ALCOHOLS BY MEANS OF AZEOTROPICALLY DRIED ENZYME COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095628-A1 | METHOD FOR THE PRODUCTION OF CHIRAL, SECONDARY ALCOHOLS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2005-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304451-A1 | PROCESS FOR THE PREPARATION OF AN ENANTIOMERICALLY AND/OR DIASTEREOMERICALLY ENRICHED ESTER, THIOESTER, ALCOHOL OR THIOL | ADH1C, ACOT7, ADH5 | MAPT 2689/4885KMT2A 976/4885CYP1A2 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.